Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/880
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStockigt, Jim R.-
dc.date.accessioned2016-11-11T01:46:45Z-
dc.date.available2016-11-11T01:46:45Z-
dc.date.issued2009-02-
dc.identifier.citationAust N Z J Obstet Gynaecol. 2009 Feb;49(1):64-6.en_US
dc.identifier.issn1479-828Xen_US
dc.identifier.urihttp://hdl.handle.net/11434/880-
dc.publisherWileyen_US
dc.subjectAntithyroid Agentsen_US
dc.subjectAdministration & Dosageen_US
dc.subjectBreast Feedingen_US
dc.subjectDose-Response Relationship, Drugen_US
dc.subjectDrug Administration Scheduleen_US
dc.subjectHormone Replacement Therapyen_US
dc.subjectHyperthyroidismen_US
dc.subjectDrug Therapyen_US
dc.subjectHypothyroidismen_US
dc.subjectComplicationsen_US
dc.subjectPregnancyen_US
dc.subjectPregnancy Complicationsen_US
dc.subjectProduct Labelingen_US
dc.subjectThyroxineen_US
dc.subjectAustraliaen_US
dc.subjectDepartment of Endocrinology and Diabetes, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectUroRenal, Vascular Clinical Institute, Epworth HealthCare, Victoria, Australiaen_US
dc.subjectObstetrics and Gynaecology Clinical Institute, Epworth HealthCare, Victoria, Australia-
dc.titleObstetric implications of current Australian product information for thyroid-related medications.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1111/j.1479-828X.2008.00944.xen_US
dc.identifier.journaltitleAustralian and New Zealand Journal of Obstetrics and Gynaecologyen_US
dc.description.pubmedurihttps://www.ncbi.nlm.nih.gov/pubmed/19281582en_US
dc.description.affiliatesMonash University, Victoria, Australiaen_US
dc.description.affiliatesAlfred Hospital, Melbourne, Victoria, Australiaen_US
dc.type.contenttypeTexten_US
Appears in Collections:UroRenal, Vascular
Women's and Children's

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.